A groundbreaking shift in Canadian drug policy has occurred, as the regulators permit the use of psilocybin fungi for therapeutic applications. Until now, these substances were severely restricted, but a increasing body of evidence suggests they potentially offer benefits here for psychological issues like anxiety. This change represents a substant